BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35437860)

  • 41. Common mechanism in endothelin-3 and PAF receptor function for anti-inflammatory responses.
    Sato A; Ebina K
    Eur J Pharmacol; 2013 Oct; 718(1-3):30-3. PubMed ID: 24055926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of PAF-acether antagonists on active anaphylactic mouse paw edema.
    Amorim CZ; Henriques MG; Weg VB; Cordeiro RS; Vargaftig BB
    Lipids; 1991 Dec; 26(12):1396-9. PubMed ID: 1668123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice.
    Amorim CZ; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1993 May; 236(2):301-4. PubMed ID: 8319756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
    Casals-Stenzel J
    Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of PAF-acether in the anaphylactic shock in the rat.
    Damas J
    J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A lethal role of platelet activating factor in anaphylactic shock in mice.
    Terashita Z; Imura Y; Shino A; Nishikawa K
    J Pharmacol Exp Ther; 1987 Oct; 243(1):378-83. PubMed ID: 3118009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction.
    Choi IW; Kim YS; Kim DK; Choi JH; Seo KH; Im SY; Kwon KS; Lee MS; Ha TY; Lee HK
    J Exp Med; 2003 Jul; 198(1):145-51. PubMed ID: 12835479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
    J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer activity of targeted proapoptotic peptides.
    Capello A; Krenning EP; Bernard BF; Breeman WA; Erion JL; de Jong M
    J Nucl Med; 2006 Jan; 47(1):122-9. PubMed ID: 16391196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recognition of nucleic acid base by tryptophan-containing peptides: spectroscopic study on interaction of N-acetylTrp-(Gly)m-Asp-(Gly)n-TrpNHCH3 (m = 0-2, n = 0-2) with guanine base.
    Kafuku Y; Ohnishi J; Doi M; Inoue M; Ishida T
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):231-4. PubMed ID: 8500195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
    Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
    Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
    Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
    J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.
    Fernández-Gallardo S; Gijón MA; García C; Furio V; Liu FT; Sánchez Crespo M
    Br J Pharmacol; 1992 Jan; 105(1):119-25. PubMed ID: 1596674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
    Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
    J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino acid sequence of Desulfovibrio vulgaris flavodoxin.
    Dubourdieu M; Fox JL
    J Biol Chem; 1977 Feb; 252(4):1453-63. PubMed ID: 402366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of peptides related to immunoglobulin E (IgE) and the examination of their pharmacological activity.
    Noguchi K; Matsuo K; Ohta N
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2463-6. PubMed ID: 2285976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amino acid sequence of a specific antigenic peptide of protein B23.
    Chan PK; Chan WY; Yung BY; Cook RG; Aldrich MB; Ku D; Goldknopf IL; Busch H
    J Biol Chem; 1986 Oct; 261(30):14335-41. PubMed ID: 2429957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.